Geo News
Community curated by people like you
Latest
AI
Crypto
Health
World Affairs
US Politics
US FDA reverses course on Regenxbio's rare-disease gene therapy, backs accelerated approval bid | Reuters — Reuters
US FDA reverses course on Regenxbio's rare-disease gene therapy, backs accelerated approval bid | Reuters
Reuters
View source article
Featured Stories
OpenAI pauses development of Astra AI model over critical cybersecurity capability concerns
Aug 7, 2026
·
2 sources
US FDA reverses course on Regenxbio's rare-disease gene therapy, backs accelerated approval bid | Reuters — Reuters